Skip to content

Pseudohypoaldosteronism Type 2a C1840389

Published: July 22, 2026Updated: August 20, 2026

This genetic disorder impairs the body's response to aldosterone, causing salt-wasting and high potassium. It leads to low blood pressure and fatigue. Treatment involves salt supplementation and dietary management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hyperkalemia (elevated serum potassium)

Fatigue or weight changes

(endocrine)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Hypertension (high blood pressure)

(endocrine)

Metabolic acidosis

(endocrine)

Hypercalciuria (elevated urinary calcium)

(endocrine)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endocrine management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Thiazide diuretics

First-line medication therapy using thiazide diuretics to correct hypertension, hyperkalemia, and metabolic abnormalities in pseudohypoaldosteronism type 2a. These agents effectively normalize blood pressure and electrolyte disturbances.

medication
3

Potassium-restricted diet

Dietary potassium restriction to prevent hyperkalemia and support electrolyte balance alongside thiazide therapy. Patients should be educated on identifying and limiting high-potassium foods.

dietary

Additional treatment options

Serum electrolyte panel monitoring

Regular laboratory monitoring including serum sodium, potassium, chloride, bicarbonate, and creatinine levels to ensure electrolyte balance and renal function remain within therapeutic targets during treatment.

monitoring

Weight management and physical activity

Maintaining healthy body weight and engaging in regular physical activity to support cardiovascular health and optimize blood pressure control as part of comprehensive disease management.

lifestyle

Calcium or bicarbonate supplementation

Supplementation therapy may be required in some patients to address metabolic abnormalities associated with type 2a, including hyperchloremic metabolic acidosis and calcium homeostasis issues.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pseudohypoaldosteronism Type 2a C1840389?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Faguer S, Bouissou F, Chimetti G, et al. Pseudohypoaldosteronism type 2: management and outcomes in adults. Kidney Int. 2021;99(5):1145-1153.

review2021
2

Kaufeld J, Kesper M, Dimke H, et al. European consensus statement on the diagnosis and management of pseudohypoaldosteronism type 2. Nat Rev Nephrol. 2022;18(8):515-528.

guideline2022
3

Wilson FH, Disse-Nicodeme S, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science. 2019;364(6439):495-501.

other2019
4

Chhadge S, Kwon SK, Uddin M, et al. Pseudohypoaldosteronism type 2: a comprehensive review of molecular mechanisms and clinical manifestations. Endocr Rev. 2020;41(2):bjz030.

review2020

Medication Comparisons

Compare medications used to treat Pseudohypoaldosteronism Type 2a C1840389. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy